National Asset Management »

Adaptimmune Therapeutics shares owned by National Asset Management

Quarter-by-quarter ownership of Adaptimmune Therapeutics (ADAP) shares owned by National Asset Management from 13F filings

Historical chart of National Asset Management investment in Adaptimmune Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Adaptimmune Therapeutics held by National Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Adaptimmune Therapeutics by National Asset Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $65k 500k 0.13
2023-06-30 $11k 12k 0.93